Please check your internet connection and try again.
# Mega%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520cv
## Overview
Mega%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520cv is a potent combination product, typically used in critical care settings for hemodynamic support. It is a vasopressor and inotrope.
## Primary Indications
* Management of severe hypotension and shock unresponsive to fluid resuscitation.
* Cardiogenic shock.
* Septic shock.
## Adult Dosing
Dosing is highly individualized and dependent on patient response and hemodynamic parameters.
* **Initial Infusion:** Typically initiated at 0.01 to 0.1 mcg/kg/min.
* **Titration:** Infusion rate is titrated upward to achieve target mean arterial pressure (MAP), usually ≥ 65 mmHg. Maximum doses vary but can range from 1 to 2 mcg/kg/min or higher depending on the specific product and clinical situation.
## Pediatric Dosing
Dosing in pediatrics is complex and often guided by institutional protocols.
* **Infusion:** May range from 0.05 to 1 mcg/kg/min, but specific protocols should be consulted.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustment is universally recommended, but caution is advised due to potential accumulation. Close hemodynamic monitoring is essential.
* **Hepatic Impairment:** No specific dose adjustment is universally recommended, but caution is advised due to potential for altered metabolism. Close hemodynamic monitoring is essential.
## Contraindications
* Known hypersensitivity to the drug or its components.
* Certain tachyarrhythmias or arrhythmias that may be exacerbated by catecholamine stimulation.
## Adverse Effects
Common adverse effects are related to excessive sympathetic stimulation:
* Tachycardia, arrhythmias
* Hypertension
* Peripheral ischemia, vasoconstriction
* Headache
* Anxiety, tremors
* Nausea, vomiting
## Key Drug Interactions
* **Monoamine Oxidase Inhibitors (MAOIs):** May potentiate pressor effects; concurrent use is generally contraindicated.
* **Tricyclic Antidepressants (TCAs):** May potentiate pressor effects.
* **Other Vasopressors/Inotropes:** Concurrent use requires careful titration and monitoring for additive effects.
* **Anesthetics:** Some anesthetics can increase myocardial irritability and potentiate arrhythmias.
* **Beta-blockers:** May unmask unopposed alpha-adrenergic effects, leading to severe hypertension.
* **Alpha-blockers:** May reduce pressor effects.
## Monitoring
* Continuous hemodynamic monitoring (arterial blood pressure, heart rate, central venous pressure if available).
* Urine output.
* Peripheral perfusion.
* Cardiac rhythm.
* Electrolytes.
## Clinical Pearls
* Infuse via a central venous catheter for optimal delivery and to minimize risk of extravasation.
* Use the lowest effective dose to achieve hemodynamic goals.
* Gradually taper off the infusion to avoid rebound hypotension.
* Always have an alternative vasopressor or inotrope readily available.
***
**Disclaimer:** This information is for educational purposes only and does not constitute medical advice. It is essential to consult the most current prescribing information and institutional protocols for definitive guidance.
